Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Investors: Regulatory Rules Make Exit Paths Expensive

Sep. 23, 2005

By Jennifer Boggs

Investors: Regulatory Rules Make Exit Paths Expensive

Sep. 23, 2005

By Jennifer Boggs

Midwest Venture Conference Opens Today In Minneapolis

Sep. 21, 2005

By Jennifer Boggs

Axonyx Reports Expected' Miss With Phenserine In AD

Sep. 21, 2005

By Jennifer Boggs

Midwest Venture Conference Opens Today In Minneapolis

Sep. 21, 2005

By Jennifer Boggs

Axonyx Reports Expected' Miss With Phenserine In AD

Sep. 21, 2005

By Jennifer Boggs

Athenagen Raises $5.7M For New Angiogenesis Pathway

Sep. 20, 2005

By Jennifer Boggs

Athenagen Raises $5.7M For New Angiogenesis Pathway

Sep. 20, 2005

By Jennifer Boggs

Geron Brings In $72M For Telomerase Work, Trials

Sep. 19, 2005

By Jennifer Boggs

Geron Brings In $72M For Telomerase Work, Trials

Sep. 19, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.